Smad2/3 is involved in growth inhibition of mouse embryonic palate mesenchymal cells induced by all-trans retinoic acid

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 85, Issue 9, 2009, Pages 780-790

  Wang, Miao ^a   Huang, Hongzhang ^a   Chen, Yiyang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

All trans retinoic acid; Cell cycle; Embryonic palate mesenchymal cells; p21; Smad2 3

Indexed keywords

MESSENGER RNA; PROTEIN P21; RETINOBLASTOMA PROTEIN; RETINOIC ACID; SMAD2 PROTEIN; SMAD3 PROTEIN; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELLULAR DISTRIBUTION; CLEFT PALATE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO; EMBRYO CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GESTATION PERIOD; GROWTH INHIBITION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MESENCHYME CELL; MOUSE; MOUSE EMBRYO; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CELL CYCLE; CLEFT PALATE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE SILENCING; MESODERM; MICE; PALATE; RNA, SMALL INTERFERING; SMAD2 PROTEIN; SMAD3 PROTEIN; TERATOGENS; TRETINOIN;

ATRA; RODENTIA;

EID: 70349186848     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20588     Document Type: Article

References (38)

1. Abbott BD, Birnbaum LS. 1990. Retinoic acid-induced alterations in the expression of growth factors in embryonic mouse palatal shelves. Teratology 42:597-610.
2. Abbott BD, Harris MW, Birnbaum LS. 1989. Etiology of retinoic acidinduced cleft palate varies with the embryonic stage. Teratology 40:533-553.
3. Abbott BD, Pratt RM. 1991. Retinoic acid alters epithelial differentiation during palatogenesis. J Craniofac Genet Dev Biol 11:315-325.
4. Campbell JL Jr, Smith MA, Fisher JW, Warren DA. 2004. Dose-response for retinoic acid-induced forelimb malformations and cleft palate: a comparison of computerized image analysis and visual inspection. Birth Defects Res B Dev Reprod Toxicol 71:289-295.
5. Clagett-Dame M, DeLuca HF. 2002. The role of vitamin A in mammalian reproduction and embryonic development. Annu Rev Nutr 22:347-381. (Pubitemid 35229924)
6. Dhulipala VC, Welshons WV, Reddy CS. 2006. Cell cycle proteins in normal and chemically induced abnormal secondary palate development: a review. Hum Exp Toxicol 25:675-682.
7. Dimberg A, Oberg F. 2003. Retinoic acid-induced cell cycle arrest of human myeloid cell lines. Leuk Lymphoma 44:1641-1650. (Pubitemid 37221036)
8. Fitzpatrick DR, Denhez F, Kondaiah P, Akhurst RJ. 1990. Differential expression of TGF beta isoforms in murine palatogenesis. Development 109:585-595. (Pubitemid 20228653)
9. Garcia-Wilson E, Perkins ND. 2005. p21WAF1/CIP1 regulates the p300 sumoylation motif CRD1 through a C-terminal domain independently of cyclin/CDK binding. Cell Cycle 4:1113-1119. (Pubitemid 41365372)
10. Greene RM, Nugent P, Mukhopadhyay P, et al. 2003. Intracellular dynamics of Smad-mediated TGFbeta signaling. J Cell Physiol 197:261-271. (Pubitemid 37485255)
11. Hilliard SA, Yu L, Gu S, et al. 2005. Regional regulation of palatal growth and patterning along the anterior-posterior axis in mice. J Anat 207:655-667. (Pubitemid 41723375)
12. Lai L, Bohnsack BL, Niederreither K, Hirschi KK. 2003. Retinoic acid regulates endothelial cell proliferation during vasculogenesis. Development 130:6465-6474. (Pubitemid 38088847)
13. Liu M, Iavarone A, Freedman LP. 1996. Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem 271:31723-31728. (Pubitemid 26408639)
14. Marazita ML, Mooney MP. 2004. Current concepts in the embryology and genetics of cleft lip and cleft palate. Clin Plast Surg 31:125-140. (Pubitemid 38638146)
15. Molinari M. 2000. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif 33:261-274. (Pubitemid 30807736)
16. Morriss-Kay GM, Iseki S, Johnson D. 2001. Genetic control of the cell proliferation-differentiation balance in the developing skull vault: roles of fibroblast growth factor receptor signalling pathways. Novartis Found Symp 232:102-116, discussion 116-121.
17. Morriss-Kay GM, Murphy P, Hill RE, Davidson DR. 1991. Effects of retinoic acid excess on expression of Hox-2.9 and Krox-20 and on morphological segmentation in the hindbrain of mouse embryos. EMBO J 10:2985-2995. (Pubitemid 21905317)
18. Nakao A, Imamura T, Souchelnytskyi S, et al., ten Dijke P. 1997. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 16:5353-5362.
19. Nugent P, Ma L, Greene RM. 1998. Differential expression and biological activity of retinoic acid-induced TGFbeta isoforms in embryonic palate mesenchymal cells. J Cell Physiol 177:36-46. (Pubitemid 28421519)
20. Okano J, Suzuki S, Shiota K. 2007. Involvement of apoptotic cell death and cell cycle perturbation in retinoic acid-induced cleft palate in mice. Toxicol Appl Pharmacol 221:42-56. (Pubitemid 46702276)
21. Pan W, Cox S, Hoess RH, Grafstrom RH. 2001. A cyclin D1/cyclindependent kinase 4 binding site within the C domain of the retinoblastoma protein. Cancer Res 61:2885-2891. (Pubitemid 32691930)
22. Pardali K, Kowanetz M, Heldin CH, Moustakas A. 2005. Smad pathwayspecific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1). J Cell Physiol 204:260-272. (Pubitemid 40776829)
23. Pardali K, Kurisaki A, Moren A, et al. 2000. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J Biol Chem 275:29244-29256. (Pubitemid 32043793)
24. Rice DP. 2005. Craniofacial anomalies: from development to molecular pathogenesis. Curr Mol Med 5:699-722.
25. Ross SA, McCaffery PJ, Drager UC, De Luca LM. 2000. Retinoids in embryonal development. Physiol Rev 80:1021-1054.
26. Rothman KJ, Moore LL, Singer MR, et al. 1995. Teratogenicity of high vitamin A intake. N Engl J Med 333:1369-1373.
27. Shenefelt RE. 1972. Morphogenesis of malformations in hamsters caused by retinoic acid: relation to dose and stage at treatment. Teratology 5:103-118.
28. Shi Y, Massague J. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685-700. (Pubitemid 36724933)
29. Vandersea MW, McCarthy RA, Fleming P, Smith D. 1998. Exogenous retinoic acid during gastrulation induces cartilaginous and other craniofacial defects in Fundulus heteroclitus. Biol Bull 194:281-296. (Pubitemid 28338456)
30. Vandromme M, Chailleux C, Escaffit F, Trouche D. 2008. Binding of the retinoblastoma protein is not the determinant for stable repression of some E2F-regulated promoters in muscle cells. Mol Cancer Res 6:418-425.
31. Wang L, Mear JP, Kuan CY, Colbert MC. 2005. Retinoic acid induces CDK inhibitors and growth arrest specific (Gas) genes in neural crest cells. Dev Growth Differ 47:119-130. (Pubitemid 40676934)
32. Wang W, Kirsch T. 2002. Retinoic acid stimulates annexin-mediated growth plate chondrocyte mineralization. J Cell Biol 157:1061-1069. (Pubitemid 34839780)
33. Wyszynski DF, Beaty TH. 2002. Phenotypic discordance in a family with monozygotic twins and nonsyndromic cleft lip and palate: follow-up. Am J Med Genet 110:182-183.
34. Yu L, Gu S, Alappat S, et al. 2005a. Shox2-deficient mice exhibit a rare type of incomplete clefting of the secondary palate. Development 132:4397-4406. (Pubitemid 41576700)
35. Yu Z, Li W, Lu Q, et al. 2008. p21 is required for atRA-mediated growth inhibition of MEPM cells, which involves RAR. J Cell Biochem 104:2185-2192.
36. Yu Z, Lin J, Xiao Y, et al. 2005b. Induction of cell-cycle arrest by all-trans retinoic acid in mouse embryonic palatal mesenchymal (MEPM) cells. Toxicol Sci 83:349-354. (Pubitemid 40227904)
37. Yu Z, Xing Y. 2006. atRA-induced apoptosis of mouse embryonic palate mesenchymal cells involves activation of MAPK pathway. Toxicol Appl Pharmacol 215:57-63. (Pubitemid 44118404)
38. Zhang Y, Feng XH, Derynck R. 1998. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 394: 909-913. (Pubitemid 28410915)